DHR
Danaher Corporation
223.20
USD
This page is just a preview of the data found in TrendSpider’s full version
Danaher Corporation stock is up 12.8% since 30 days ago. The next earnings date is Jan 23, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 68% of the previous 49 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 8 CALLs, 2 PUTs.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 28 Nov 18:27 | 15 Mar, 2024 | 190.00 | 86 | ||
| 29 Nov 14:47 | 15 Dec, 2023 | 200.00 | 862 | ||
| 29 Nov 15:52 | 19 Jan, 2024 | 220.00 | 1370 | ||
| 29 Nov 17:39 | 15 Dec, 2023 | 210.00 | 1262 | ||
| 29 Nov 18:50 | 16 Jan, 2026 | 190.00 | 77 | ||
| 29 Nov 20:11 | 01 Dec, 2023 | 225.00 | 819 | ||
| 29 Nov 20:38 | 01 Dec, 2023 | 225.00 | 819 | ||
| 30 Nov 14:54 | 15 Mar, 2024 | 200.00 | 666 | ||
| 30 Nov 16:53 | 17 Jan, 2025 | 230.00 | 145 | ||
| 01 Dec 14:42 | 15 Mar, 2024 | 200.00 | 667 |
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics.
